Dr. Backes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3651 Ridge Mill Dr
Hilliard, OH 43026Phone+1 614-293-3873Fax+1 614-293-3078
Summary
- Dr. Floor Backes is a gynecologic oncologist and obstetrician/gynecologist in Columbus, OH and is affiliated with multiple hospitals in the area, including The Ohio State University James Cancer Hospital and Ohio State University Wexner Medical Center. She received her medical degree from University of Groningen Faculty of Medical Science and has been in practice 13 years. She specializes in gynecologic oncology and is highly experienced in endometrial cancer, cervical cancer, vulva cancer, germ cell tumors, sex cord/stromal tumors, gestational trophoblastic disease, ovarian cancer, fallopian tube carcinoma, primary peritoneal cancer and other. She has more than 100 publications and over 500 citings.
Education & Training
- Ohio State University/Mt Carmel HospitalFellowship, Gynecologic Oncology, 2009 - 2012
- Ohio State University/Mt Carmel HospitalResidency, Obstetrics and Gynecology, 2005 - 2009
- University of Groningen Faculty of Medical ScienceClass of 2004
Certifications & Licensure
- OH State Medical License 2009 - 2025
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Best Doctors 2018
- Best Doctors Best Doctors, 2017
- Excellence in Teaching Award Department of OBGYN, 2016
- Join now to see all
Clinical Trials
- Lymph Node Mapping in Patients With Endometrial Cancer Start of enrollment: 2013 Mar 01
- Lenvatinib and Weekly Paclitaxel for Patients With Recurrent Endometrial or Ovarian Cancer Start of enrollment: 2016 May 27
- Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer Start of enrollment: 2018 Jul 12
- Join now to see all
Publications & Presentations
PubMed
- Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without Radiotherapy for Newly Diagnosed, High-Risk Endometrial Cancer: Results in Mismatch Repair-Deficien...Brian M Slomovitz, David Cibula, Weiguo Lv, Fırat Ortaç, Sakari Hietanen
Journal of Clinical Oncology. 2025-01-20 - Clinical trial enrollment during first course of gynecologic cancer treatment and survival.Wafa Khadraoui, Jennifer A Sinnott, Caitlin E Meade, Jesse Plascak, Autumn Carey
Gynecologic Oncology. 2025-01-01 - Real-world outcomes of first-line maintenance niraparib monotherapy in patients with epithelial ovarian cancer.Ritu Salani, Tirza Areli Calderón Boyle, Jonathan Lim, Jeanne M Schilder, Jean A Hurteau
Future Oncology. 2025-01-01
Journal Articles
- Pelvic and para-aortic lymphadenectomy in gynecologic cancersJeffrey Fowler and Floor Backes, UpToDate, 1/17/2015
- DNA Glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 an BRCA2 mutation carriersOsorio A, Milne RL, Kuchenbaecker K, Vaclova T, Pita G, Alonso R, Peterlongo P, Blanco I, de la Hoya M, Duran M, Diez O, Ramon Y Cajal T, Konstantopoulou I, Martínez-B..., PLoS Genet, 1/1/2014
- Performance of PREMM1,2,6, MMRpredict, and MMRpro in detecting Lynch syndrome among endometrial cancer cases Colon Cancer Family Registry (CCFR)Mercado RC, Hampel H, Kastrinos F, Steyerberg E, Balmana J, Stoffel E, Cohn DE, Backes FJ, Hopper JL, Jenkins MA, Lindor NM, Casey G, Haile R, Madhavan S, de la Chapel..., Annual American Society for Clinical Oncology national meeting, J Clin Oncol, Genet Med, 1/1/2012
- Join now to see all
Abstracts/Posters
- Insulin-like growth factor 1 receptor expression increases with body mass index in 894 endometrial carcinomasJoehlin-Price A, Stephens J, Backes F, Cohn D, Suarez A, Mod Pathol, 1/1/2015
- Adherence to a standard algorithm results in high negative predictive value of sentinel lymph node assessment using indocyanine green (ICG) and isosulfane blue (ISB) d...Floor Backes, David Cohn, Ritu Salani, David O’Malley, Larry Copeland, Adrian Suarez, David Cohen, Jeffrey Fowler, Society of Gynecologic Oncologists 46th Annual Meeting on Women’s Cancer, Gynecol Oncol, Chicago, IL, 1/1/2015
- Outcomes in Stage III endometrial cancer are similar for chemotherapy +/- radiation in type I and type II histologiesCasey Cosgrove, Garima Agrawal, Ritu Salani, Larry Copeland, Jeffrey Fowler, David Cohn, David O’Malley, Floor Backes, Society of Gynecologic Oncologists 46th Annual Meeting on Women’s Cancer, Gynecol Oncol, Chicago, IL, 1/1/2015
- Join now to see all
Lectures
- Salpingectomy: Why and WhenColumbus, OH - 1/1/2015
- Gynecologic Oncology Case Review1/1/2015
- Ovarian Cancer1/1/2015
- Join now to see all
Press Mentions
- Lenvima Prompts Durable Responses in Ovarian, Endometrial CancersMarch 20th, 2019
- Surgical-Pathological Findings in Type 1 and 2 Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study on GOG-210 ProtocolJune 1st, 2017
- Addressing Knowledge Gaps in the Treatment of Advanced Endometrial CancerFebruary 17th, 2024
- Join now to see all
Committees
- Co-Chair Developmental Therapeutics Committee, NRG Oncology 2018 - Present
- Vice Chair, Cancer Institutional Review Board (Cancer IRB) 2017 - Present
- Member, Uterine Task Force (UTF) of the NCI Gynecologic Cancer Steering Committee (GCSC) 2017 - Present
- Member, , Society of Gynecologic Oncology Clinical Practice Committee. 2016 - Present
- Member, Rare Tumor Committee, Gynecologic Oncology Group/NRG Oncology 2013 - Present
Professional Memberships
- Society of Gynecologic OncologyMember
- American Congress of Obstetricians and GynecologistsMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: